Patent ID: 6994863
Filing Date: 2006-02-07
Classification: A21D,A23C,A23D,A23G,A23J,A23L,A23P,A61K,A61P,A61Q,Y10S

Abstract:
1. A method of treating a disease or disorder of a skin or a mucosal membrane comprising: topically administering to the skin or the mucosal membrane a pharmaceutical composition containing, by weight, 1–25 percent of a solidifying agent, wherein the solidifying agent consists essentially of at least one long chain fatty alcohol having at least 15 carbons atoms in its carbon backbone and at least one fatty acid, having at least 18 carbon atoms in its carbon backbone, and 75–99 percent of a hydrophobic solvent, wherein at least one of the solidifying agent and the hydrophobic agent has a therapeutic or cosmetic beneficial effect, and wherein the solidifying agent and the hydrophobic solvent are selected such that under ambient conditions, the composition is semi-solid a rest and liquefies upon application of shear forces thereto, wherein the disease or disorder is selected from the group consisting of psoriasis, acne, seborrhea, seborrheic dermatitis, alopecia and excessive hair growth, ichthyosis, wounds, burns, cuts, ulcers, psoriasis, seborrheic dermatitis of the face and trunk, seborrheic blepharitis, contact dermatitis, stasis dermatitis and exfoliative dermatitis.